1.Outcomes of open heart surgery in patients with end-stage renal disease
Jung Hwa PARK ; Jeong Hoon LIM ; Kyung Hee LEE ; Hee Yeon JUNG ; Ji Young CHOI ; Jang Hee CHO ; Chan Duck KIM ; Yong Lim KIM ; Hanna JUNG ; Gun Jik KIM ; Sun Hee PARK
Kidney Research and Clinical Practice 2019;38(3):399-406
BACKGROUND: Cardiovascular diseases of chronic dialysis patients are often undertreated because of their higher surgical risk. This study aimed to assess mortality and morbidity after open heart surgery in chronic dialysis patients compared to those with normal renal function and identify risk factors for postoperative outcomes. METHODS: We retrospectively analyzed 2,432 patients who underwent open heart surgery from 2002 to 2017 and collected data from 116 patients (38 patients on dialysis and 78 age-, sex-, and diabetes mellitus status-matched control patients with normal kidney function). We assessed comorbidities, New York Heart Association (NYHA) class, laboratory data, surgical methods, and postoperative outcomes. RESULTS: The dialysis group had more comorbidities, higher NYHA classes, and greater need for urgent surgeries compared to the control group. They exhibited significantly higher postoperative mortality (18.4% vs. 2.6%, P = 0.005) and more overall complications (65.8% vs. 25.6%, P < 0.001). Dialysis itself significantly increased relative risk for in-hospital mortality after adjustment. EuroSCORE II was not as useful as in the general population. Multivariate logistic regression analysis demonstrated that total (adjusted odds ratio [AOR], 10.7; P = 0.029) and in-hospital death risk (AOR, 14.7; P = 0.033), the durations of postoperative hospitalization (AOR, 4.6; P = 0.034), CRRT (AOR 36.8; P = 0.004), and ventilator use (AOR, 7.6; P = 0.022) were significantly increased in the dialysis group. CONCLUSION: The dialysis group exhibited a higher risk for mortality and overcall complications after open heart surgery compared to the patients with normal renal function. Therefore, the benefit of surgical treatment must be balanced against potential risks.
Cardiovascular Diseases
;
Comorbidity
;
Diabetes Mellitus
;
Dialysis
;
Heart
;
Hospital Mortality
;
Hospitalization
;
Humans
;
Kidney
;
Kidney Failure, Chronic
;
Logistic Models
;
Mortality
;
Odds Ratio
;
Renal Insufficiency
;
Retrospective Studies
;
Risk Factors
;
Thoracic Surgery
;
Ventilators, Mechanical
2.The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial
Ji Young CHOI ; Dong Ki KIM ; Yang Wook KIM ; Tae Hyun YOO ; Jung Pyo LEE ; Hyun Chul CHUNG ; Kyu Hyang CHO ; Won Suk AN ; Duk Hyun LEE ; Hee Yeon JUNG ; Jang Hee CHO ; Chan Duck KIM ; Yong Lim KIM ; Sun Hee PARK
Journal of Korean Medical Science 2018;33(9):e74-
BACKGROUND: Appropriate immunosuppressive therapy for patients with idiopathic membranous nephropathy (MN) remains controversial. The effect of mycophenolate mofetil (MMF) versus cyclosporine (CsA) combined with low-dose corticosteroids was evaluated in patients with idiopathic MN in a multi-center randomized trial (www.ClinicalTrials.gov NCT01282073). METHODS: A total of 39 biopsy-proven idiopathic MN patients with severe proteinuria were randomly assigned to receive MMF combined with low-dose corticosteroids (MMF group) versus CsA combined with low-dose corticosteroids (CsA group), respectively, and followed up for 48 weeks. Complete or partial remission rate of proteinuria and estimated glomerular filtration rate (eGFR) at 48 weeks were compared. RESULTS: The level of proteinuria at baseline and at 48 weeks was 8.9 ± 5.9 and 2.1 ± 3.1 g/day, respectively, in the MMF group compared to 8.4 ± 3.5 and 3.2 ± 5.7 g/day, respectively, in the CsA group. In total, 76.1% of the MMF group and 66.7% of the CsA group achieved remission at 48 weeks (95% confidence interval, −0.18 to 0.38). There was no difference in eGFR between the two groups. Anti-phospholipase A2 receptor Ab levels at baseline decreased at 48 weeks in the complete or partial remission group (P = 0.001), but were unchanged in the no-response group. There were no significant differences between the two groups in changes in the Gastrointestinal Symptom Rating Scale and Gastrointestinal Quality of Life Index scores from baseline to 48 weeks. CONCLUSION: In combination with low-dose corticosteroids, the effect of MMF may not be inferior to that of CsA in patients with idiopathic MN, with similar adverse effects including gastrointestinal symptoms. Trial registry at ClinicalTrials.gov (www.ClinicalTrials.gov NCT01282073).
Adrenal Cortex Hormones
;
Cyclosporine
;
Glomerular Filtration Rate
;
Glomerulonephritis, Membranous
;
Humans
;
Proteinuria
;
Quality of Life
3.Severe ileus after colonoscopy in a patient on peritoneal dialysis.
Sang Un KIM ; Su Hee KIM ; So Yoon HWANG ; Ryang Hi KIM ; Ji Young CHOI ; Jang Hee CHO ; Chan Duck KIM ; Yong Lim KIM ; Sun Hee PARK
Yeungnam University Journal of Medicine 2017;34(1):119-122
Peritoneal dialysis (PD) is associated with the development of various complications, such as exit site infection or peritonitis, and rarely, intestinal obstruction in prolonged PD patients with recurrent peritonitis. However, post-colonoscopy acute intestinal obstruction has not been reported in PD patients to date. Herein, we report a case of severe ileus after a colonoscopy without previous episodes of peritonitis in a PD patient. A 51-year-old man undergoing PD for 7 years visited our emergency department due to severe abdominal pain and vomiting after colonoscopic polypectomy. A simple abdominal radiography and abdominal computed tomography showed ileus with collapsed distal ileal loop. A peritoneal dialysate study revealed no evidence of peritonitis. The patient was treated with decompression therapy, and ileus was successfully treated without complications. This case suggests that it is not only necessary to prevent peritonitis, but also important to monitor the development of ileus after colonoscopy in PD patients.
Abdominal Pain
;
Colonoscopy*
;
Decompression
;
Emergency Service, Hospital
;
Humans
;
Ileus*
;
Intestinal Obstruction
;
Middle Aged
;
Peritoneal Dialysis*
;
Peritonitis
;
Radiography, Abdominal
;
Vomiting
4.Severe ileus after colonoscopy in a patient on peritoneal dialysis
Sang Un KIM ; Su Hee KIM ; So Yoon HWANG ; Ryang Hi KIM ; Ji Young CHOI ; Jang Hee CHO ; Chan Duck KIM ; Yong Lim KIM ; Sun Hee PARK
Yeungnam University Journal of Medicine 2017;34(1):119-122
Peritoneal dialysis (PD) is associated with the development of various complications, such as exit site infection or peritonitis, and rarely, intestinal obstruction in prolonged PD patients with recurrent peritonitis. However, post-colonoscopy acute intestinal obstruction has not been reported in PD patients to date. Herein, we report a case of severe ileus after a colonoscopy without previous episodes of peritonitis in a PD patient. A 51-year-old man undergoing PD for 7 years visited our emergency department due to severe abdominal pain and vomiting after colonoscopic polypectomy. A simple abdominal radiography and abdominal computed tomography showed ileus with collapsed distal ileal loop. A peritoneal dialysate study revealed no evidence of peritonitis. The patient was treated with decompression therapy, and ileus was successfully treated without complications. This case suggests that it is not only necessary to prevent peritonitis, but also important to monitor the development of ileus after colonoscopy in PD patients.
Abdominal Pain
;
Colonoscopy
;
Decompression
;
Emergency Service, Hospital
;
Humans
;
Ileus
;
Intestinal Obstruction
;
Middle Aged
;
Peritoneal Dialysis
;
Peritonitis
;
Radiography, Abdominal
;
Vomiting
5.Churg-Strauss syndrome that presented with mediastinal lymphadenopathy and calculous cholecystitis.
Jung Yoon CHOI ; Ji Eun KIM ; In Young CHOI ; Ju Han LEE ; Je Hyeong KIM ; Chol SHIN ; Seung Heon LEE
The Korean Journal of Internal Medicine 2016;31(1):179-183
No abstract available.
Adult
;
Biopsy
;
Cholecystitis/diagnostic imaging/*etiology/therapy
;
Churg-Strauss Syndrome/*complications/diagnosis/drug therapy
;
Diagnosis, Differential
;
Female
;
Gallstones/diagnostic imaging/*etiology/therapy
;
Glucocorticoids/therapeutic use
;
Humans
;
Lymphadenopathy/diagnostic imaging/*etiology/therapy
;
Magnetic Resonance Imaging
;
Mediastinum
;
Methylprednisolone/therapeutic use
;
Predictive Value of Tests
;
Tomography, X-Ray Computed
;
Treatment Outcome
6.Low prealbumin levels are independently associated with higher mortality in patients on peritoneal dialysis.
Kyung Hee LEE ; Jang Hee CHO ; Owen KWON ; Sang Un KIM ; Ryang Hi KIM ; Young Wook CHO ; Hee Yeon JUNG ; Ji Young CHOI ; Chan Duck KIM ; Yong Lim KIM ; Sun Hee PARK
Kidney Research and Clinical Practice 2016;35(3):169-175
BACKGROUND: Prealbumin, a sensitive marker for protein–energy status, is also known as an independent risk factor for mortality in hemodialysis patients. We investigated the impact of prealbumin on survival in incident peritoneal dialysis (PD) patients. METHODS: In total, 136 incident PD patients (mean age, 53.0 ± 15.8 years) between 2002 and 2007 were enrolled in the study. Laboratory data, dialysis adequacy, and nutritional parameters were assessed 3 months after PD initiation. Patients were classified into 2 groups according to prealbumin level: high prealbumin (≥ 40 mg/dL) and low prealbumin (< 40 mg/dL). RESULTS: The patients in the low-prealbumin group were older and had more comorbidities such as diabetes and cardiovascular diseases compared with the patients in the high-prealbumin group. Mean subjective global assessment scores were lower, and the high-sensitivity C-reactive protein levels were higher in the low-prealbumin group. Serum creatinine, albumin, and transferrin levels; percent lean body mass; and normalized protein catabolic rate were positively associated, whereas subjective global assessment scores and high-sensitivity C-reactive protein levels were negatively associated with prealbumin concentration. During the median follow-up of 49 months, patients in the lower prealbumin group had a higher mortality rate. Multivariate analysis revealed that prealbumin < 40 mg/dL (hazard ratio, 2.30; 95% confidence interval, 1.14–4.64) was an independent risk factor for mortality. In receiver operating characteristic curves, the area under the curve of prealbumin for mortality was the largest among the parameters. CONCLUSION: Prealbumin levels were an independent and sensitive predictor for mortality in incident PD patients, showing a good correlation with nutritional and inflammatory markers.
C-Reactive Protein
;
Cardiovascular Diseases
;
Comorbidity
;
Creatinine
;
Dialysis
;
Follow-Up Studies
;
Humans
;
Inflammation
;
Mortality*
;
Multivariate Analysis
;
Peritoneal Dialysis*
;
Prealbumin*
;
Renal Dialysis
;
Risk Factors
;
ROC Curve
;
Transferrin
7.Heterotopic ossification in appendiceal mucinous neoplasms: clinicopathological characteristics of 3 cases
Choi SY ; Park S ; Kim KH ; Kim SH
The Malaysian Journal of Pathology 2016;38(1):49-54
Heterotopic bone formation is a very rare event in the gastrointestinal tract including in the appendix.
Here we report three cases of heterotopic ossification in appendiceal mucinous neoplasms, one
occurring in an appendiceal mucinous cystadenoma, another in a low-grade appendiceal mucinous
neoplasm, and the third occurring in an appendiceal mucinous adenocarcinoma. The clinicopathologic
characteristics of these three present cases and two previously reported cases are discussed in detail.
The mechanism of heterotopic ossification in appendiceal mucinous neoplasm is still unclear, but
mucin extravasation and subsequent calcification may be predisposing events.
8.Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
Ga Young PARK ; Chung Hoon YU ; Jun Seop KIM ; Yun Jeong KANG ; Owen KWON ; Ji Young CHOI ; Jang Hee CHO ; Chan Duck KIM ; Yong Lim KIM ; Sun Hee PARK
The Korean Journal of Internal Medicine 2015;30(3):345-353
BACKGROUND/AIMS: Neutrophil gelatinase-associated lipocalin (NGAL) is a well-known biomarker of acute kidney injury. We evaluated the value of plasma NGAL (pNGAL) as an independent predictor of prognosis in immunoglobulin A nephropathy (IgAN). METHODS: In total, 91 patients with biopsy-proven IgAN at a single center were evaluated. pNGAL was measured using a commercial enzyme-linked immunosorbent assay kit (R&D Systems). Adverse renal outcome was defined as chronic kidney disease (CKD) stage 3 or above at the last follow-up. Pearson correlation coefficient and Cox regression were used for analyses. RESULTS: The mean age of all patients (male:female, 48:43) was 35 years (range, 18 to 77). pNGAL ranged between 21.68 and 446.40 ng/mL (median, 123.97) and showed a correlation with age (r = 0.332, p = 0.001), creatinine (r = 0.336, p = 0.001), estimated glomerular filtration rate (r = -0.397, p < 0.001), uric acid (r = 0.289, p = 0.006), and the protein-to-creatinine ratio (r = 0.288, p = 0.006). During a mean follow-up period of 37.6 months, 11 patients (12.1%) had CKD stage 3 or above. In a multivariate Cox regression model, hypertension (hazard ratio [HR], 8.779; 95% confidence interval [CI], 1.526 to 50.496; p = 0.015), proteinuria > 1 g/day (HR, 5.184; 95% CI, 1.124 to 23.921; p = 0.035), and pNGAL (HR, 1.012; 95% CI, 1.003 to 1.022; p = 0.013) were independent predictors associated with adverse renal outcome. CONCLUSIONS: pNGAL showed strong correlations with other clinical prognostic factors and was also an independent predictor of adverse renal outcome. We suggest pNGAL as a potential predictor for prognosis in IgAN, while further studies are needed to confirm the clinical value.
Acute-Phase Proteins
;
Adolescent
;
Adult
;
Aged
;
Biomarkers/blood
;
Biopsy
;
Chi-Square Distribution
;
Creatinine/blood
;
Disease Progression
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Glomerular Filtration Rate
;
Glomerulonephritis, IGA/*blood/complications/pathology/physiopathology
;
Humans
;
Kidney/*metabolism/pathology/physiopathology
;
Linear Models
;
Lipocalins/*blood
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Predictive Value of Tests
;
Prognosis
;
Proportional Hazards Models
;
Proto-Oncogene Proteins/*blood
;
Renal Insufficiency, Chronic/blood/etiology
;
Republic of Korea
;
Retrospective Studies
;
Risk Factors
;
Time Factors
;
Young Adult
9.Multiple Embolic Aortic Valve Endocarditis with Small Patent Ductus Arteriosus in Adult.
Seon Hee KIM ; Seunghwan SONG ; Min Su KIM ; Sang Pil KIM ; Jung Hyun CHOI
The Korean Journal of Thoracic and Cardiovascular Surgery 2014;47(2):137-140
A 50-year-old female was admitted to Pusan National University Hospital with complaints of fatigue and sweating. Echocardiography showed a small patent ductus arteriosus (PDA) and highly mobile vegetations on the aortic valve. Emergency operation was performed due to the high risk of embolization and severe aortic regurgitation. When the pulmonary artery opened, we found unexpected fresh vegetation. The tissue of the PDA was fragile and infected. We successfully removed the infected tissue, closed the PDA with a patch, and replaced the aortic valve with a mechanical prosthesis.
Adult*
;
Aortic Valve Insufficiency
;
Aortic Valve*
;
Busan
;
Ductus Arteriosus, Patent*
;
Echocardiography
;
Emergencies
;
Endocarditis*
;
Fatigue
;
Female
;
Humans
;
Middle Aged
;
Prostheses and Implants
;
Pulmonary Artery
;
Sweat
;
Sweating
10.Encapsulating peritoneal sclerosis: case series from a university center.
Kyung Deuk HONG ; Ji Hea BAE ; Yun Jin JANG ; Hee Yeon JUNG ; Jang Hee CHO ; Ji Young CHOI ; Chan Duck KIM ; Yong Lim KIM ; Sun Hee PARK
The Korean Journal of Internal Medicine 2013;28(5):587-593
BACKGROUND/AIMS: Encapsulating peritoneal sclerosis (EPS) is an often-fatal complication of long-term peritoneal dialysis (PD). We here report the clinical features of EPS in Korean PD patients from a single university center. METHODS: The data were collected retrospectively from 606 PD patients at Kyungpook National University Hospital, between August 2001 and August 2011. The diagnosis of EPS was based on clinical signs and symptoms, and confirmed by radiological findings. RESULTS: Eight patients (1.3%, four males) were diagnosed with EPS. The mean age of the patients was 48.5 years (range, 33 to 65). The mean duration of PD was 111.8 months (range, 23 to 186). All patients except for one had three or more episodes of peritonitis. Seven patients were diagnosed with EPS after stopping PD, and only one stayed on PD after initial diagnosis and treatment. Total parenteral nutrition and corticosteroids, in addition to tamoxifen therapy, were used to treat most of the patients, and one patient underwent surgery (adhesiolysis). The overall mortality rate was 50%. CONCLUSIONS: EPS is a serious, life-threatening complication in patients on long-term PD. To reduce the incidence and mortality rate of EPS, careful monitoring and early diagnosis is needed.
Adrenal Cortex Hormones/therapeutic use
;
Adult
;
Aged
;
Female
;
*Hospitals, University
;
Humans
;
Male
;
Middle Aged
;
Parenteral Nutrition, Total
;
Peritoneal Dialysis/*adverse effects/mortality
;
*Peritoneal Fibrosis/diagnosis/etiology/mortality/therapy
;
*Peritonitis/diagnosis/etiology/mortality/therapy
;
Republic of Korea
;
Retrospective Studies
;
Tamoxifen/therapeutic use
;
Time Factors
;
Tomography, X-Ray Computed
;
Treatment Outcome

Result Analysis
Print
Save
E-mail